Structures by: Badami B.
Total: 13
2-(4-Chlorophenyl)-4-(2-hydroxyethyl)-5-methyl-2,4-dihydro- 3H-1,2,4-triazol-3-one
C11H12ClN3O2
Acta Crystallographica Section E (2003) 59, 1 o75-o76
a=12.6968(4)Å b=11.1886(3)Å c=7.9872(2)Å
α=90.00° β=95.4460(10)° γ=90.00°
3-(4-Chlorophenyl)-5-methyl-3H-1,3,4-oxadiazole-2-one
C9H7ClN2O2
Acta Crystallographica Section E (2004) 60, 6 o964-o965
a=6.8548(14)Å b=12.042(2)Å c=22.762(5)Å
α=90.00° β=90.00° γ=90.00°
Dimethyl 1-(7-acetoxy-4-methyl-2-oxo-2H-chromen-8-ylmethyl)-1H-pyrazole- 3,4-dicarboxylate
C20H18N2O8
Acta Crystallographica Section E (2004) 60, 6 o961-o963
a=23.1233(17)Å b=12.7597(9)Å c=15.2076(11)Å
α=90.00° β=116.0320(10)° γ=90.00°
N-(4-Acetylphenyl)-N'-[(4-sydnone-3-yl)phenyl]urea dimethylformamide solvate
C17H14N4O4,C3H7NO
Acta Crystallographica Section E (2004) 60, 6 o1015-o1016
a=7.7954(8)Å b=8.3922(8)Å c=16.9225(17)Å
α=79.057(2)° β=84.267(2)° γ=65.049(2)°
Dimethyl 1-{4-[4,5-bis(methoxycarbonyl)-1,2,3-triazol-1- ylmethylcarbonyl]phenyl}-1H-pyrazole-3,4-dicarboxylate
C21H19N5O9
Acta Crystallographica Section E (2005) 61, 10 o3482-o3484
a=12.0798(12)Å b=8.5500(6)Å c=21.424(2)Å
α=90.00° β=90.070(9)° γ=90.00°
2-(4-Bromophenyl)-5-methyl-2,3-dihydro-4H-1,2,4-triazol-3-one
C9H8BrN3O
Acta Crystallographica Section E (2003) 59, 2 o225-o226
a=4.03330(10)Å b=10.8622(2)Å c=21.1608(4)Å
α=90.00° β=93.9045(7)° γ=90.00°
3-(4-Methoxyphenyl)-4-(4-phenyl-1,3-butadienoyl)sydnone
C20H16N2O4
Acta Crystallographica Section E (2003) 59, 6 o894-o896
a=12.0961(8)Å b=4.7750(4)Å c=15.3516(12)Å
α=90.00° β=97.719(3)° γ=90.00°
3-[4-(1-Oxo-3-phenylprop-2-en-1-yl)phenyl]sydnone
C17H12N2O3
Acta Crystallographica Section E (2003) 59, 11 o1762-o1763
a=7.5839(8)Å b=7.9343(7)Å c=23.543(2)Å
α=90.00° β=92.954(8)° γ=90.00°
4-Amino-2-(p-chlorophenyl)-5-methyl-3,4-dihydro-2H-1,2,4-triazol-3-one
C9H9ClN4O
Acta Crystallographica Section E (2003) 59, 7 o964-o966
a=4.0135(8)Å b=11.691(2)Å c=11.986(2)Å
α=117.09(3)° β=90.79(3)° γ=91.89(3)°
Ethyl 4-[1-(4-bromophenyl)-3-methyl-5-oxo-4,5-dihydro- 1H-1,2,4-triazol-4-yliminomethyl]phenoxyacetate
C20H19BrN4O4
Acta Crystallographica Section E (2003) 59, 9 o1272-o1274
a=8.5176(7)Å b=15.5566(12)Å c=17.2643(15)Å
α=113.407(6)° β=94.601(7)° γ=103.763(6)°
3-[(7-Acetoxy-4-methylcoumarin-8-yl)methyl]sydnone
C15H12N2O6
Acta Crystallographica Section E (2004) 60, 4 o701-o702
a=11.5067(3)Å b=13.1916(3)Å c=9.1773(2)Å
α=90.00° β=95.6210(9)° γ=90.00°
5-Phenoxymethyl-1,3,4-oxadiazole-2(3H)-thione
C9H8N2O2S
Acta Crystallographica Section E (2005) 61, 11 o3746-o3747
a=9.3233(8)Å b=4.9446(5)Å c=10.2051(10)Å
α=90.00° β=91.388(5)° γ=90.00°
Methyl [8-(3,5-dimethylpyrazol-1-ylmethyl)-4-methyl-2-oxo-2H-chromen-7- yloxy]acetate 0.19-hydrate
C19H20N2O5,0.19H2O
Acta Crystallographica Section E (2004) 60, 7 o1213-o1214
a=8.8151(9)Å b=10.6692(11)Å c=10.9050(11)Å
α=96.281(2)° β=108.032(2)° γ=108.383(2)°